APA (7th ed.) Citation

M, M., A, I., E, A., M, B., F, S., G, B., . . . D, R. (2021). Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study. Cancer medicine, 10(5), 1726. https://doi.org/10.1002/cam4.3778

Chicago Style (17th ed.) Citation

M, Malagola, et al. "Molecular Response and Quality of Life in Chronic Myeloid Leukemia Patients Treated with Intermittent TKIs: First Interim Analysis of OPTkIMA Study." Cancer Medicine 10, no. 5 (2021): 1726. https://doi.org/10.1002/cam4.3778.

MLA (9th ed.) Citation

M, Malagola, et al. "Molecular Response and Quality of Life in Chronic Myeloid Leukemia Patients Treated with Intermittent TKIs: First Interim Analysis of OPTkIMA Study." Cancer Medicine, vol. 10, no. 5, 2021, p. 1726, https://doi.org/10.1002/cam4.3778.